Literature DB >> 15732353

[Prevention of elderly pneumonia by pneumococcal, influenza and BCG vaccinations].

Takashi Ohrui1, Katsutoshi Nakayama, Takeyasu Fukushima, Hiroshi Chiba, Hidetada Sasaki.   

Abstract

Pneumonia is a major cause of morbidity and mortality in elderly people, especially in those with chronic medical conditions such as chronic heart and lung diseases. We prospectively examined the effect of influenza and pneumococcal vaccinations on the rate of hospitalization for and complications of pneumonia, all respiratory tract conditions and mortality in elderly bedridden patients and found that both febrile days and pneumonia cases decreased. Thus, these results show that it is valuable to vaccinate for influenza elderly people even if they are confined to bed. Furthermore, the tuberculin skin test is an easy method to check the cell-mediated immunity in the elderly people. In the tuberculin skin test, all Japanese over 65 years old should have positive status. A negative result indicates depressed cell-mediated immunity. We undertook a trial to vaccinate tuberculin negative elderly people with BCG vaccine and found that the risk of pneumonia is decreased to a similar degree to that in subjects with positive tuberculin test results. We conclude that vaccination might be an effective strategy for the prevention of pneumonia in elderly people with limited activities of daily living.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15732353     DOI: 10.3143/geriatrics.42.34

Source DB:  PubMed          Journal:  Nihon Ronen Igakkai Zasshi        ISSN: 0300-9173


  23 in total

1.  Efficacy of Bacillus Calmette-Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial.

Authors:  Sanjeev Sinha; Anuj Ajayababu; Himanshu Thukral; Sushil Gupta; Subhasish Kamal Guha; Ayan Basu; Gaurav Gupta; Prashant Thakur; Raghavendra Lingaiah; Bimal Kumar Das; Urvashi B Singh; Ravinder Singh; Rajiv Narang; Dipankar Bhowmik; Naveet Wig; Dolan Champa Modak; Bhaswati Bandyopadhyay; Banya Chakrabarty; Aditya Kapoor; Satyendra Tewari; Narayan Prasad; Zia Hashim; Alok Nath; Niraj Kumari; Ravinder Goswami; Shivam Pandey; Ravindra Mohan Pandey
Journal:  Infect Dis Ther       Date:  2022-10-15

2.  Exploration of Association Between Respiratory Vaccinations With Infection and Mortality Rates of COVID-19.

Authors:  Deldar Morad Abdulah; Alan Bapeer Hassan
Journal:  Disaster Med Public Health Prep       Date:  2021-02-16       Impact factor: 1.385

Review 3.  Bacillus Calmette-Guerin (BCG): the adroit vaccine.

Authors:  Oluwafolajimi A Adesanya; Christabel I Uche-Orji; Yeshua A Adedeji; John I Joshua; Adeniyi A Adesola; Chibuike J Chukwudike
Journal:  AIMS Microbiol       Date:  2021-02-08

4.  Bacillus Calmette-Guérin-induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 mice.

Authors:  Bao-Zhong Zhang; Huiping Shuai; Hua-Rui Gong; Jing-Chu Hu; Bingpeng Yan; Terrence Tsz-Tai Yuen; Ye-Fan Hu; Chaemin Yoon; Xiao-Lei Wang; Yuxin Hou; Xuansheng Lin; Xiner Huang; Renhao Li; Yee Man Au-Yeung; Wenjun Li; Bingjie Hu; Yue Chai; Ming Yue; Jian-Piao Cai; Guang Sheng Ling; Ivan Fan-Ngai Hung; Kwok-Yung Yuen; Jasper Fuk-Woo Chan; Jian-Dong Huang; Hin Chu
Journal:  JCI Insight       Date:  2022-06-08

5.  Is Immuno-modulation the Key to COVID-19 Pandemic?

Authors:  Ajay Gupta
Journal:  Indian J Orthop       Date:  2020-04-27       Impact factor: 1.251

Review 6.  Gut Microbiota Dysbiosis-Immune Hyperresponse-Inflammation Triad in Coronavirus Disease 2019 (COVID-19): Impact of Pharmacological and Nutraceutical Approaches.

Authors:  Carolina Ferreira; Sofia D Viana; Flávio Reis
Journal:  Microorganisms       Date:  2020-10-01

Review 7.  Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and "New Old Friends".

Authors:  Thomas-Oliver Kleen; Alicia A Galdon; Andrew S MacDonald; Angus G Dalgleish
Journal:  Front Immunol       Date:  2020-09-04       Impact factor: 7.561

8.  Safety and COVID-19 Symptoms in Individuals Recently Vaccinated with BCG: a Retrospective Cohort Study.

Authors:  Simone J C F M Moorlag; Rosanne C van Deuren; Cornelis H van Werkhoven; Martin Jaeger; Priya Debisarun; Esther Taks; Vera P Mourits; Valerie A C M Koeken; L Charlotte J de Bree; Thijs Ten Doesschate; Maartje C Cleophas; Sanne Smeekens; Marije Oosting; Frank L van de Veerdonk; Leo A B Joosten; Jaap Ten Oever; Jos W M van der Meer; Nigel Curtis; Peter Aaby; Christine Stabell-Benn; Evangelos J Giamarellos-Bourboulis; Marc Bonten; Reinout van Crevel; Mihai G Netea
Journal:  Cell Rep Med       Date:  2020-08-05

9.  Overcoming immune dysfunction in the elderly: trained immunity as a novel approach.

Authors:  Ozlem Bulut; Gizem Kilic; Jorge Domínguez-Andrés; Mihai G Netea
Journal:  Int Immunol       Date:  2020-11-23       Impact factor: 4.823

10.  "Trained immunity" from Mycobacterium spp. exposure or BCG vaccination and COVID-19 outcomes.

Authors:  Samer Singh; Rajendra Prakash Maurya; Rakesh K Singh
Journal:  PLoS Pathog       Date:  2020-10-29       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.